Preparation of Hydroxyapatite/Poly(ε-caprolactone) Hybrid Microspheres for Drug Release System


Article Preview

Hydroxyapatite(HA) nanoparticles with hydrophobic surface have been synthesized using mono-alkyl phosphate (MAP) as modifier by hydrothermal synthesis method. The drug-loaded nano-HA/ Poly(ε-caprolactone)(PCL)composite microspheres and drug-load PCL microspheres were fabricated by an S/O/W emulsion solvent evaporation method. The microspheres morphology was investigated by scanning electron microscopy (SEM). Drug distribution in microsphere matrix was studied by confocal laser scanning microscope (CLSM). The results showed that the drug distributed evenly in the drug-HA-PCL microspheres, but only around the surface of the drug-PCL microspheres. The drug release profile showed that the nano-HA/PCL hybrid microspheres had low initial burst and could release continually for 90 days. This kind of hybrid microspheres can be used as a promising long-term drug delivery system in the bone.



Key Engineering Materials (Volumes 330-332)

Main Theme:

Edited by:

Xingdong Zhang, Xudong Li, Hongsong Fan, Xuanyong Liu




S. H. Zhang et al., "Preparation of Hydroxyapatite/Poly(ε-caprolactone) Hybrid Microspheres for Drug Release System", Key Engineering Materials, Vols. 330-332, pp. 1045-1048, 2007

Online since:

February 2007




[1] L.D. Silvio and W. Bonfieid: J. Mater. Sci: Mater. Med. Vol. 10 (1999), p.653.

[2] T.J. Wua, H.H. Huanga, F.Y. Hsu and Y.J. Wang: Biomaterials Vol. 25 (2004), p.651.

[3] M. Sivakumar and K. P. Rao: J Biomed Mater Res Vol. 65A(2003), p.222.

[4] H. W. Kim and H. E. Kim: J Biomed Mater Res Part B: Appl Biomater Vol. 70B (2004), p.240.

[5] M.D. Dhanaraju and C. Vamsadhara: J. Biomed. Mater. Res. Vol. 76A (2006), p.63.

[6] F. Barbato, M.I.L. Rotonda, R. Palumbo and F. Quaglia: Biomaterials Vol. 22 (2001), p.1371.

[7] R.S.R. Murthy: Biodegradable polymers. In: Jain, N.K. (Eds. ), Controlled and Novel Drug Delivery. (CBS Publisher, New Delhi, 1997).

[8] S. Prior, C. Gamazo, J.M. Irache and B. Gander, Int. J. Pharm. Vol. 196 (2000), p.115.